0001613801-26-000028.txt : 20260430 0001613801-26-000028.hdr.sgml : 20260430 20260430143037 ACCESSION NUMBER: 0001613801-26-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260427 FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Susi Roger E. CENTRAL INDEX KEY: 0001613801 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 26923533 MAIL ADDRESS: STREET 1: C/O IRADIMED CORPORATION STREET 2: 12705 INGENUITY DRIVE CITY: ORLANDO STATE: FL ZIP: 32826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 731408526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12705 INGENUITY DRIVE CITY: ORLANDO STATE: FL ZIP: 32826 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 12705 INGENUITY DRIVE CITY: ORLANDO STATE: FL ZIP: 32826 4 1 wk-form4_1777573833.xml FORM 4 X0609 4 2026-04-27 0 0001325618 IRADIMED CORP IRMD 0001613801 Susi Roger E. false C/O IRADIMED CORPORATION 12705 INGENUITY DRIVE ORLANDO FL 32826 1 1 1 0 CEO, President, Chairman 1 Common Stock 2026-04-27 4 S 0 2819 88.98 D 2199681 I By Phillip Susi 2008 Dynasty Trust Common Stock 2026-04-27 4 S 0 931 89.70 D 2198750 I By Phillip Susi 2008 Dynasty Trust Common Stock 2026-04-28 4 S 0 998 84.13 D 2197752 I By Phillip Susi 2008 Dynasty Trust Common Stock 2026-04-28 4 S 0 847 85.77 D 2196905 I By Phillip Susi 2008 Dynasty Trust Common Stock 2026-04-28 4 S 0 742 86.52 D 2196163 I By Phillip Susi 2008 Dynasty Trust Common Stock 2026-04-28 4 S 0 900 88 D 2195263 I By Phillip Susi 2008 Dynasty Trust Common Stock 2026-04-28 4 S 0 263 88.81 D 2195000 I By Phillip Susi 2008 Dynasty Trust Common Stock 162950 I By Roger E. Susi Revocable Trust Common Stock 2062500 I By Matthew Susi 2008 Dynasty Trust The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. This transaction was executed in multiple trades at prices ranging from $88.47 to $89.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $89.54 to $90.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $83.75 to $84.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $85.20 to $86.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $86.21 to $87.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $87.65 to $88.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $88.66 to $88.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. /s/ Roger E. Susi 2026-04-30